Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-09-18 00:00:00 ET · period of report 2024-07-11 · accession 0001628280-24-040833 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-18 | 2024-07-11+ | BLFS | Berard Todd | CMO | S - Sale | $23.39 | -736 | 108.6K | -0.7% | -$17.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-16 | S | D | 367 | $25.12 | 108,158 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-21 | S | D | 82 | $25.61 | 108,525 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-11 | S | D | 287 | $20.54 | 108,607 | D | — | — |